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Abstract
The changes in global gene expression in response to DNA damage may derive from either direct
induction or repression by transcriptional regulation or indirectly by synchronization of cells to
specific cell cycle phases, such as G1 or G2. We developed a model that successfully estimated the
expression levels of >400 cell cycle-regulated genes in normal human fibroblasts based on the
proportions of cells in each phase of the cell cycle. By isolating effects on the gene expression
associated with the cell cycle phase redistribution after genotoxin treatment, the direct transcriptional
target genes were distinguished from genes for which expression changed secondary to cell
synchronization. Application of this model to ionizing radiation (IR)-treated normal human
fibroblasts identified 150 of 406 cycle-regulated genes as putative direct transcriptional targets of
IR-induced DNA damage. Changes in expression of these genes after IR treatment derived from both
direct transcriptional regulation and cell cycle synchronization.
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INTRODUCTION
Cell proliferation is a fundamental biological activity that is regulated through many gene
products, including cyclin-dependent kinases (CDKs), enzymes for DNA replication and
repair, enzymes for chromatin condensation and segregation, proto-oncogenes, and tumor
suppressor genes.1,2 Many cell cycle regulators undergo dramatic changes in levels of
expression and activity to propel or regulate progression through the cell division cycle.3
Identification of cell cycle-regulated genes will facilitate understanding of not only normal
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biological processes during cell division but also mechanisms of pathologic response to
environmental toxicants.
Microarray technology enables researchers to determine changes in expression of thousands
of genes in cells and tissues in response to treatment with exogenous chemicals or drugs.4,5
A commonly addressed question in microarray experiments is which genes are direct
transcriptional targets of carcinogen-induced DNA damage, and which are altered secondarily
to inhibition of cell cycle progression following DNA damage? It is not uncommon for
hundreds or even thousands of genes to be changed significantly after a specific drug or toxicant
treatment. However, toxic agents that cause DNA damage, such as IR, UV and
chemotherapeutic drugs for cancer, usually inhibit cell proliferation by activating cell cycle
checkpoint functions and causing growth arrest at specific cell cycle phases.2,6,7 The
synchronizing effect of the cell cycle checkpoint response to DNA damage can affect the
expression of cell cycle- or growth-regulated genes at later times8,9 masking direct
transcriptional targets.
To quantify the effects on gene expression resulting from changes in the proportions of cells
in G1, S, G2 and M phases of the cell division cycle, a baseline level for all transcripts in each
of these phases must first be established, and then gene expression in a population of cells can
be estimated when the proportionate distribution of cells in the various cycle compartments is
known. Although global transcriptional regulation during the cell cycle has been widely
investigated in many organisms using microarray technology,1,3,10–15 none of the current
methods used to synchronize cells results in 100% of the cells in a specific cell cycle phase.
Furthermore, the cells become asynchronous with time after release from the synchronizing
block. Therefore, the measured transcript levels do not truly represent a pure cell population.
In the present study, a model was developed to determine “true” expression levels of genes in
each pure cell cycle phase. Cell-cycle-specific gene expression patterns and cell cycle-
regulated genes were further identified by EPIG method.16 Once the levels of cell cycle-
regulated genes in pure G1, S, G2 or M phase cells were obtained, we were able to isolate effects
of DNA damage-induced redistribution of cell cycle phases on expression of cell cycle-
regulated genes, and then to identify direct transcriptional targets of a genotoxin.
MATERIALS AND METHODS
Cell lines and culture
Normal human fibroblasts, NHF1, NHF3 and NHF10, were derived from neonatal foreskins
and established in culture according to established methods.17 Immortalized cell lines were
obtained by ectopic expression of human telomerase (hTERT), as previously described.18,
19 Fibroblasts were cultured in DMEM high-glucose medium (Invitrogen, Carlsbad, CA USA)
supplemented with 2 mM L-glutamine (Invitrogen, Carlsbad, CA, USA) and 10% fetal bovine
serum (FBS, Sigma Chemical Co, St. Louis, MO, USA). All cell lines were maintained at 37°
C in a humidified atmosphere of 5% CO2 and were routinely tested and shown to be free of
mycoplasma contamination using a commercial kit (Gen-Probe, San Diego, CA, USA).
Cell irradiation
Cells were exposed to ionizing radiation in their culture medium, using a 137Cs source
(Gammacell of Canada) at a dose rate of 0.84 Gy/min. Sham-treated controls were subjected
to the same movements in and out of incubators as irradiated cells.
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Cell cycle compartment determination
For quantification of G1, S and G2 phase cells, 10 μM 5′-bromo-2′-deoxyuridine (BrdU, Sigma
Chemical Co.) was added to culture medium at various times after irradiation to label S phase
cell DNA and cultures were incubated for another 2 hours. Cells were harvested, washed with
phosphate-buffered saline (PBS), and fixed with 67% ethanol in PBS. Cells were stained with
fluorescein isothiocyanate (FITC)-conjugated anti-BrdU antibody (BD Biosciences, San Jose,
CA, USA) and propidium iodide (PI, Sigma Chemical Co., St. Louis, MO, USA), then G1, S
and G2 phase cells were enumerated by flow cytometry as previously described.20–22 For
analysis of M phase cells, cells were harvested at various times after irradiation, washed with
PBS, fixed in 1% formaldehyde in PBS for 30 min, and then fixed in 67% ethanol in PBS.
Cells were incubated in 0.5 μg/100μl anti-phospho-histone H3 antibody (Upstate
Biotechnology Inc., Lake Placid, NY, USA) for 2 h, and then stained with FITC-conjugated
anti-rabbit antibody (Santa Cruz) and propidium iodide.23–25 Flow cytometric analyses to
enumerate mitotic cells were done using a FACScan flow cytometer and Summit software
(DakoCytomation, Fort Collins, CO, USA).
Cell synchronization
NHF1, NHF3 and NHF10 cells were synchronized as previously described.19,26,27 Briefly,
cells were plated at a density of 1.3 × 104/cm2 and allowed to grow for 8 days to confluence-
arrest in G0 phase. During this time cell growth medium was changed on days 3 and 5 post-
seeding. Arrested cells were released from dishes with trypsin, reseeded at 1.3 × 104/cm2 and
then incubated for 8 h to allow them to reach mid G1. Cells similarly released from G0 were
incubated with the DNA polymerase inhibitor, aphidicolin (APC), at a concentration of 2 μg/
ml for 24 h to collect cells at the beginning of S. APC was washed out and cells incubated for
3 hr to allow accumulation to mid S phase. Cells that were released from APC treatment also
were incubated for 8 h to accumulate in G2. Colcemid at 100 ng/ml was added to such G2 cells
and cells were incubated an additional 4 h to collect cells in mitosis (M). Ten million cells were
harvested at each cell cycle phase for RNA isolation. Two million cells were sampled for flow
cytometric analysis of DNA content by staining with propidium iodide. Modfit commercial
software (Verity Software House Inc.,Topsham, ME, USA) was used to determine the
proportions of cells in G0/G1, S and G2/M. The proportions of cells in M were determined by
flow cytometric enumeration of phospho-histone H3-expressing cells with 4N DNA content.
Oligo DNA microarray
Total RNA was isolated from synchronized cell populations using a Qiagen RNeasy kit. The
quality of all RNA samples was confirmed using an Agilent 2100 Bioanalyzer. Microarray
analysis was then performed through a contract with Icoria Corporation as follows. Briefly, 1
μg of sample RNA and global reference RNA (Stratagene, La Jolla, CA, USA) were converted
to cDNA with reverse transcriptase then amplified using T7 RNA polymerase while labeling
with either Cy3-dUTP or Cy5-dUTP (Agilent’s Low RNA Input Linear Amplification Kit,
Agilent Techologies, USA). The quality of each labeled cRNA was evaluated using an Agilent
2100 Bioanalyzer prior to hybridization. 750 ng of Cy3 and Cy5-labeled cRNA were used in
the hybridization. The labeled cRNA from samples was hybridized with the labeled global
reference cRNA on an Agilent 22k human 1A array (Agilent Techologies, USA) in a
hybridization oven (Robbins Scientific Model 400, 1040-60-1AG, Sunnyvale, CA, USA) at
60°C for 17 h. Hybridization of sample RNA against reference RNA was done twice with a
fluorophore reversal (dye swap). Following hybridization, the arrays were scanned using the
Agilent DNA Microarray Scanner with SureScan® Technology and microarray images were
analyzed using Agilent Feature Extraction Software (v7.1).
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Computational analysis of microarray data
(1) Cell cycle-regulated gene extraction. As previously reported26 and shown in (Table 1), the
synchronization methods yielded populations of cells that were highly enriched in selected
cycle-phase compartments but the synchronization was imperfect. Cultures synchronized in
G1 phase displayed 82–91% 2N DNA content with small proportions of cells in S, G2 and M.
Cultures that were synchronized to S, G2 and M displayed 46–71%, 54–70% and 23–32% of
cells in these phases, respectively. Global gene expression profiles were generated from the
synchronized cell populations. To calculate theoretically “pure” G1-, S-, G2- or M-specific
gene expression levels, four simultaneous equations were derived for each gene based on the
microarray-determined expression levels and the proportions of cells in each cycle phase for
each of the synchronized samples. The expression levels of a gene in G1, S, G2, or M, assuming
that it has a linear relationship with the proportion of cells in each cycle compartment, may be
expressed as:
genei,G1 = fG1,G1 × GENEi,G1 + f S,G1 × GENEi,s + fG2,G1 × GENEi,G2 + fM,G1 × GENEi,M
genei,G2 = fG1,G2 × GENEi,G1 + f S,G2 × GENEi,s + fG2,G2 × GENEi,G2 + fM,G2 × GENEi,M
genei,S = fG1,S × GENEi,G1 + f S,S × GENEi,S + fG2,S × GENEi,G2 + fM,S × GENEi,M
genei,M = fG1,M × GENEi,G1 + f S,M × GENEi,S + fG2,M × GENEi,G2 + fM,M × GENEi,M
where genei,j is the measured expression level of gene i in cultures synchronized in phase j that
is an average of the duplicate arrays (C3 or C5 labeling), j ∈ {G1,G2,S,M}· fj,G1, is the fraction
of G1 cells in cultures synchronized in phase j ; conversely for fj,S, fj,G2 and fj,M · GENEi,j is
the expression level of gene i if the gene was expressed in a perfectly synchronized phase j.
The equations were simultaneously solved to calculate “pure” G1-, S-, G2- and M-specific
expression levels. In this model, interactions between genes or cell cycle compartments were
assumed to have no effect on the equations.
A targeted evaluation of 45 well-known cell cycle-regulated genes demonstrated that the model
expanded the range of variation in expression levels across the cell cycle. The levels of
transcripts specific to M cells were most impacted by the model (Table 2). This was to be
expected as synchronization yielded an M population representing only 22–32% of the cells,
while the model estimated transcript levels for a theoretically pure sample of mitotic cells.
GENEi,j, expression level of a gene with purity correction, was applied in EPIG analysis for
extraction of patterns of cell cycle-regulated gene expression patterns and significant genes.
In the EPIG method, the extracted log2 pixel intensity ratio values (sample vs. reference) were
preprocessed, which included systematic variation normalization, dye-swap correction, and
cell line alignment.28 Three parameters, the correlation coefficient within a specific pattern,
the magnitude of change, and the signal-to-noise ratio (SNR), were employed for selection of
significant genes.16
(2) Identification of primary transcriptional targets. Gene expression in sham- or IR-treated
cell populations was estimated using GENEi,j weighted by the proportions of cells in G1, S,
G2 and M. The estimated values were then compared with the observed values from
microarrays to distinguish changes in gene expression caused by alterations in cell cycle
distribution from changes caused directly by IR treatment. The comparisons were done by
paired t-test to identify significant genes showing difference between the estimated values and
the observed values.
(3) Gene ontology analysis of significant genes. Categories of genes that were over-represented
in a selected gene list compared to what was represented in the microarray were analyzed using
Zhou et al. Page 4













EASE (http://apps1.niaid.nih.gov/david/). Such over-represented categories represent
biological “themes” of a given list.
(4) Identification of transcription factors (TFs) in cell cycle-regulated genes. Computational
promoter analysis was done using the PRIMA software, described in detail by Elkon et al.29
Briefly, given a target set and a background set of promoters, PRIMA performs statistical tests,
based on hypergeometric distribution, aimed at identifying TFs whose binding site signatures
are significantly more prevalent in the target set than in the background set. In this study, each
of the two sets of cell cycle-regulated genes (IR-target genes and non-IR-target genes) was
considered a target set and the entire set of genes represented on the microarray served as the
background set. PRIMA uses position weight matrices (PWMs) as models for regulatory sites
that are bound by TFs. PWMs that represent human or mouse TF binding sites were obtained
from the TRANSFAC database.30 Putative promoter sequences corresponding to all known
human genes were extracted from the human genome, masking out repetitive elements
(Ensembl, version 27).31 PRIMA promoters’ scan was done on both strands and was confined
to the region from 600 bp upstream to 100 bp downstream to the putative genes’ transcription
start site.
RESULTS
Extraction of cell cycle-regulated genes
From the purity-corrected microarray data, EPIG was able to identify nine cell cycle-specific
expression patterns (Fig. 1) and 2410 genes or ESTs as cell-cycle-specific based on criteria of
three parameters: correlation coefficient within a specific pattern (r ≥ 0.64, n = 24, p <
1×10−6), the magnitude of change (log2 ratio of sample vs. reference > 0.4), and the signal-to-
noise ratio (SNR > 3, p <0.01) (Chou, Zhou, Bushel, Kaufmann and Paules, in preparation).
The number of genes in each pattern ranged from 19 to 473 (Table 3). All expected patterns
of gene expression across the cell cycle were detected. About 500 genes were expressed at
highest levels in G1 and at lower levels in S, G2 and M (Patterns 1 and 2). Over 1100 genes
were expressed at highest levels in S and at variably lower levels in G1, G2 and M (Patterns
3–7). No pattern displayed a peak of gene expression in G2 but over 700 genes in Patterns 8
and 9 displayed maximal expression in M. Among the genes that were expressed at highest
levels in G1 were the well-known growth-enhancing transcription factor Myc, and GOS2, a
gene known to be expressed highly in G1 cells and to regulate the G0 to G1 transition.32 Among
the genes expressed at highest levels in S were many whose protein products are known to be
required for DNA replication such as ORC3, ORC4, ORC6, CDC45L, CDC6, CDC7L,
MCM2, MCM3, MCM6, MCM7, POLA2, PCNA, RFC2, RFC3, and RFC5. In patterns 8 and
9 with highest expression in M were BUB1B, CCNB1, CDC20, CDC25C and PLK that are
known to regulate cell progression through G2 and M. Thus, many genes that displayed cell-
cycle-specific gene expression encode proteins that are expected to function during the phases
of maximal expression.
However, cycle-specific changes in gene expression in synchronized cell populations may not
reflect the changes that occur in physiologically cycling cell populations. Some genes selected
by above method, although showing pattern-specific expression, may not be truly cell-cycle-
regulated genes. Changes in these genes might simply reflect the G0/G1 transition (highest
expression in G1), a response to aphidicolin (highest expression in S), or a response to colcemid
(highest expression in M). For those truly cell-cycle-regulated genes, changes in expression
levels should reflect alterations in proportions in each phase of the cell cycle.
To further test the truly cell cycle-regulated genes, a second experiment was performed in
which NHF1 cells were cultured and harvested at seven different times between days 2 to 3
after reseeding. These cultures contained different proportions of cells in each cycle-phase
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(Table 4) and gene expression levels were determined for each culture by microarray. The
hypothesis for this experiment was that expression levels of cell cycle-regulated genes were
linearly correlated with the proportions of cells in each cycle phase and variations in these
proportions in normally cycling cell population would alter the levels of expression of cell
cycle-regulated genes (given that expression levels of a cell cycle-regulated gene in each pure
cell cycle phase are stable and known). Based on the measured proportions of cells in each
cycle phase in each culture, the expression levels of the 2410 cell cycle-specific genes identified
earlier were estimated to compare with the microarray-determined expression levels. A gene
was identified as cell-cycle-regulated only when its expression level was well-estimated (r >
0.75, P < 0.05) by the proportions of cells in the various cycle phases. A total of 406 genes
were confirmed as cell cycle-regulated by displaying a significant high correlation between
the estimated and the microarray-determined expression levels. GO analysis of the 406 genes
showed that all cell-cycle-related categories were significantly over-represented. The same
analysis applied to the remainder of the 2410 genes yielded 12 categories related to intracellular
processes, nucleotide and nucleic acid metabolism, and RNA binding, but no cell cycle-related
categories.
Identification of transcriptional targets of ionizing radiation
NHF1, NFH3 and NHF10 human fibroblast lines in logarithmic growth were treated with 1.5
Gy IR, a dose that inhibited colony formation by 40–45%. Cells were harvested at 2, 6 and 24
h post-IR for microarray analysis of gene expression. Quantitative analysis of cell cycle
compartments after IR treatment indicated that the proportions of G1, S, G2 and M cells changed
markedly, especially at 24 h when the G1 population was substantially enriched and the S and
M compartments were severely depleted (Table 5, Fig. 2). These changes in the distribution
of cells across the cell cycle were primarily the consequence of the p53-dependent G1
checkpoint response.33 The cell-synchronizing effects of IR leading to redistribution of cell
cycle compartments were expected to affect the expression profiles of all 406 cell cycle-
regulated genes.
According to the determined proportions of cells in each of the cycle compartments in sham-
and IR-treated cells (Table 5) and the expression levels of the 406 genes in each presumed pure
cell cycle phase, expression levels of these cell cycle-regulated genes were estimated. Changes
in expression levels (log2 ratios of sample vs reference) of the 406 genes at 2, 6 and 24 h after
IR-irradiation relative to sham-treated controls were obtained by subtracting expression level
of sham-treated samples from IR-treated samples and the estimated values and the measured
values were compared (Table 9, Supplement).
If the values were equivalent, it would suggest that changes in the expression levels of cell-
cycle-regulated genes were associated with the IR-induced cell synchronization. A total of 193
genes with changes in expression levels showing no significant difference between the
estimated values and the measured values were identified as non-targets of IR.
Alternatively, if changes in the expression levels of cell-cycle-regulated genes were associated
with IR directly affecting transcription in addition to cell synchronization, the measured
expression levels would be impacted by both of these effects, and the measured and estimated
values would be different. Accordingly, 150 genes with measured transcript levels different
than estimated values were identified as IR-target genes based on a statistical significance
criterion (paired t-test, P < 0.05) and fold change threshold (log2 ratios of sample vs reference
>0.4). These 150 genes represent putative direct transcriptional targets of IR, of which 134
were repressed and 16 were induced. Most of the IR-target genes (131) were recognized at 24
hr post-treatment, with 44 targets recognized at 6 hr and 3 targets recognized at 2 hr.
Zhou et al. Page 6













Gene ontology analysis of the 150 target genes yielded over-represented categories related to
cell cycle, cell proliferation, DNA metabolism and DNA repair. Some well-known genes were
BUB1, CCNB1, CCNB2, CDC2, CDC20, E2F1, KNSL1, KNSL7, MCM2, MCM5, MCM7,
PCNA, POLD1, RFC4, RFC5, TIMELESS, TOP2A, FANCA, RAD18, and RAD51 (Figs. 3a–
c). Among the 193 non-target genes, CCNE1, CDC45L, CDC6, CDKN2D, CENPE, CHEK1,
LIG1, MSH2, ORC6L, POLA2, and POLE were included (Fig. 3d) and over-represented
categories from gene ontology also included biological process related to cell cycle, cell
proliferation, DNA metabolism (Table 6). The 63 genes showing significant differences
between observed and predicted but with fold changes less than 0.4 need be confirmed in further
experiments.
Transcription factors involved in target and non-target cell cycle-regulated genes
Analysis of transcription factor binding sites in the promoters of the target and non-target cell-
cycle-regulated genes showed that two factors, E2F and NF-Y, were enriched in both groups
while cell cycle-dependent element (CDE) was significantly enriched in the target group and
upstream stimulating factor (USF) was significantly enriched in the non-target group (Table
7).
DISCUSSION
Cell synchronization helps identify phase-specific genes3,12,15 but does not provide
quantitatively accurate expression levels of cell cycle-specific genes because of the lack of
perfect synchrony. By applying simultaneous equations, the expression levels of genes in
theoretically pure G1, S, G2 or M cell cycle phases were estimated. These gene expression
levels were thereafter used to identify cell cycle-specific genes and to estimate the expression
levels of cell cycle-regulated genes in an asynchronous cell population based on the proportions
of G1, S, G2 and M cells. The results provide another image of the regulation of gene expression
as human cells synchronously pass through the cell division cycle, and suggest that many cell
cycle-regulated genes are actively repressed in response to IR-induced DNA damage.
It must be noted that artificially synchronized cell cycle phases do not biologically equal the
phases existing in physiologically cycling cells. Although a total of 2410 genes or ESTs
showing cell cycle-specific expression were identified based on nine extracted patterns by
using EPIG method, they were not necessarily cycle-regulated genes. Many of these genes may
have been selected because of serum stimulation after release from G0 into G1,12 or by a direct
response to aphidicolin or colcemid treatment.27 Only genes whose expression levels could
be correctly estimated in asynchronous cell populations based on the proportions of cells in
the cycle compartments were accepted as cell cycle-regulated. A total of 406 among the 2410
genes were identified as cell cycle-regulated genes.
One of the purposes of the present study was to identify the transcriptional targets of a genotoxin
among the cell cycle-regulated genes. It has been well-documented that IR induces DNA
double-strand-breaks and activates checkpoints to arrest cells in G1 and G2.2,34 Hundreds of
cell-cycle-regulated genes were observed to change in response to DNA damage.9,16,35,36
Genes that were not cell-cycle- regulated were easy to identify as transcriptional targets because
expression of these genes was not affected by the DNA damage-induced synchronization
effect. However, it is impossible in these studies to distinguish genes that were changed by
primary transcriptional regulation from genes changed resulting from cell synchrony caused
by the checkpoint response to DNA damage. Our model was developed to address this question.
The methodology used here enabled estimation of the changes of gene expression resulting
from the cell synchrony effect and identification of transcriptional targets of IR whose changes
in gene expression were greater than that from cell synchrony alone.
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Although the G2 checkpoint was clearly activated at 2 hr post-IR irradiation, the expression of
genes that are important for the G2/M transition, such as CDC2 and CCNB1, did not show any
difference between the measured and the estimated values, indicating that post-translational
modifications account for the G2 checkpoint function at this time point and changes in
expression of these genes were due to accumulation of the G2 population (Table 5, Fig. 3b).
Starting at 6 hr post-IR, the time when G1 arrest was clearly observed, the expression of some
S phase genes, like MCM2 and MCM3, showed greater repression than estimated, suggesting
a direct transcriptional repression mechanism in G1 arrest. Further at 24 h post-IR, the
expression of many important cell cycle-regulated genes, including CCNB1 and 2, CDC2,
CDC20, CDC7L1, CDK2, MCM2, 3 and 7, RFC4, TIMELESS and TOP2α showed greater
repression in the observed values also suggesting direct inhibition by IR in addition to the cell
synchrony effects. These results suggest that expression of some cell-cycle-regulated genes is
actively changed in response to DNA damage to contribute to cell cycle arrest. Many other
cell-cycle-regulated genes were just down-regulated passively in response to DNA damage
secondary to cell cycle arrest. The mechanisms of primary down-regulation of the target genes
are still not clear. p53 has been reported to play an important role in trans-repression of cell-
cycle-regulatory genes.35,37,38 Well-known p53-responsive genes include CDC2, CCNB1,
and TOP2α.39–41 Despite the transcription factors E2F and NF-Y being enriched in both
groups, cell cycle-dependent element (CDE) was significantly enriched in the target group and
upstream stimulating factor (USF) was enriched in the non-target group. Previous analyses of
CDC2 and CCNB1 promoters suggested that p53 interacted with NF-Y to mediate trans-
repression,42 although a subsequent study suggested that p53 trans-repressed through
interaction with SP1.43 Conversely several groups have reported that genes containing CDE/
CHR in their promoters, such as CCNB1, CCNB2, CDC2, TOP2A, RAD51, CENPA,
CDC25C, can be directly trans-repressed by IR-induced DNA damage through a p53-
dependent signaling pathway.44–46 Two independent mechanisms, direct binding or via CDE/
CHR element, are involved in p53-dependent transcriptional repression of some cell cycle-
regulated genes.44 Six of the above-mentioned target genes appeared in our target gene list
(Fig. 3a). The results presented here suggest that a large set of as many as 150 cell-cycle-
regulated genes may be subject to p53-dependent trans-repression in response to DNA damage.
Analysis of gene ontology in the 150 potential target genes showed that although they
distributed in various categories of biological process, cellular component and molecular
functions, almost all of the over-represented categories were related to cell cycle regulation,
DNA metabolism and cell proliferation (Table 7). Beside the post-translational modifications
of checkpoint sensors, transducers, mediators and effectors, the repression of cell cycle-
regulated genes may play an important role in cell cycle checkpoint function in response to
IR-induced DNA damage.
In our previous publication, 1811 IR-responding genes or ESTs were identified using the EPIG
method with the same criteria for significant gene extraction.16 Among the 1811 genes, 328
of the 406 cell cycle-regulated genes were identified, and all of the 150 IR-target genes were
on the list. The other 1483 genes that were IR-responsive but not cell cycle-regulated included
early DNA damage response genes, such as CDKN1A, BTG2, GADD45A, PLK2, PLK3 and
PPMD1 that initiate or regulate cell cycle checkpoint functions. Such genes may work together
with targeted repression in transcription of cell cycle-regulated genes to cause and maintain
cell cycle arrest, and with genes passively responding to G0-like growth quiescence.16
Identification of transcriptional targets of the DNA damage response helps us understand the
mechanisms of cell cycle arrest caused by direct regulation of cell cycle-regulated genes at the
level of transcription, in addition to those checkpoint functions regulated by post-translational
modification of protein. Both responses appear to play important roles in maintaining cell cycle
arrest. By accounting for the changes in gene expression that are indirect manifestations of cell
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synchronization, this model may improve elucidation of the mechanisms of genotoxicity by
environmental chemicals or therapeutic drugs that directly induce or repress transcription of
target genes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgements
Supported by PHS grants ES11391, N01-ES-25497, and ES10126. We thank George Wu, Dong Xiang and Dr. Leping
Li for help with microarray data analysis. We acknowledge PHS’s contribution of the Software EASE used in our
data analysis.
References
1. van der Meijden CM, Lapointe DS, Luong MX, Peric-Hupkes D, Cho B, Stein JL, van Wijnen AJ,
Stein GS. Gene profiling of cell cycle progression through S-phase reveals sequential expression of
genes required for DNA replication and nucleosome assembly. Cancer Res 2002;62:3233–43.
[PubMed: 12036939]
2. Abraham RT. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev
2001;15:2177–96. [PubMed: 11544175]
3. Cho RJ, Huang M, Campbell MJ, Dong H, Steinmetz L, Sapinoso L, Hampton G, Elledge SJ, Davis
RW, Lockhart DJ. Transcriptional regulation and function during the human cell cycle. Nat Genet
2001;27:48–54. [PubMed: 11137997]
4. Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA. Microarrays and toxicology: The advent of
toxicogenomics. Mol Carcinog 1999;24:153–9. [PubMed: 10204799]
5. Waters MD, Olden K, Tennant RW. Toxicogenomic approach for assessing toxicant-related disease.
Mutat Res 2003;544:415–24. [PubMed: 14644344]
6. Melo J, Toczyski D. A unified view of the DNA-damage checkpoint. Curr Opin Cell Biol 2002;14:237–
45. [PubMed: 11891124]
7. Kaufmann WK, Paules RS. DNA damage and cell cycle checkpoints. Faseb J 1996;10:238–47.
[PubMed: 8641557]
8. Jen KY, Cheung VG. Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome
Res 2003;13:2092–100. [PubMed: 12915489]
9. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation
response. Proc Natl Acad Sci USA 2001;98:5116–21. [PubMed: 11309499]
10. Cho RJ, Campbell MJ, Winzeler EA, Steinmetz L, Conway A, Wodicka L, Wolfsberg TG, Gabrielian
AE, Landsman D, Lockhart DJ, Davis RW. A genome-wide transcriptional analysis of the mitotic
cell cycle. Mol Cell 1998;2:65–73. [PubMed: 9702192]
11. Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, Nevins JR. Role for E2F in control of both
DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol
2001;21:4684–99. [PubMed: 11416145]
12. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr,
Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO. The transcriptional program in the
response of human fibroblasts to serum. Science 1999;283:83–7. [PubMed: 9872747]
13. Ren B, Cam H, Takahashi Y, Volkert T, Terragni J, Young RA, Dynlacht BD. E2F integrates cell
cycle progression with DNA repair, replication, and G2/M checkpoints. Genes Dev 2002;16:245–
56. [PubMed: 11799067]
14. Shedden K, Cooper S. Analysis of cell-cycle -specific gene expression in human cells as determined
by microarrays and double-thymidine block synchronization. Proc Natl Acad Sci USA
2002;99:4379–84. [PubMed: 11904377]
15. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM,
Hurt MM, Brown PO, Botstein D. Identification of genes periodically expressed in the human cell
cycle and their expression in tumors. Mol Biol Cell 2002;13:1977–2000. [PubMed: 12058064]
Zhou et al. Page 9













16. Zhou T, Chou JW, Simpson DA, Zhou Y, Mullen TE, Medeiros M, Bushel PR, Paules RS, Yang X,
Hurban P, Lobenhofer EK, Kaufmann WK. Profiles of global gene expression in ionizing-radiation-
damaged human diploid fibroblasts reveal synchronization behind the G1 checkpoint in a G0-like
state of quiescence. Environ Health Perspect 2006;114:553–9. [PubMed: 16581545]
17. Maher VM, Heflich RH, McCormick JJ. Repair of DNA damage induced in human fibro-blasts by
N-substituted aryl compounds. Natl Cancer Inst Monogr 1981:217–22. [PubMed: 7341979]
18. Heffernan TP, Simpson DA, Frank AR, Heinloth AN, Paules RS, Cordeiro-Stone M, Kaufmann WK.
An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced
DNA damage. Mol Cell Biol 2002;22:8552–61. [PubMed: 12446774]
19. Deming PB, Cistulli CA, Zhao H, Graves PR, Piwnica-Worms H, Paules RS, Downes CS, Kaufmann
WK. The human decatenation checkpoint. Proc Natl Acad Sci USA 2001;98:12044–9. [PubMed:
11593014]
20. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW. Participation of p53 protein in the
cellular response to DNA damage. Cancer Res 1991;51:6304–11. [PubMed: 1933891]
21. Kaufmann WK, Schwartz JL, Hurt JC, Byrd LL, Galloway DA, Levedakou E, Paules RS. Inactivation
of G2 checkpoint function and chromosomal destabilization are linked in human fibroblasts
expressing human papillomavirus type 16 E6. Cell Growth Differ 1997;8:1105–14. [PubMed:
9342189]
22. Kaufmann WK, Heffernan TP, Beaulieu LM, Doherty S, Frank AR, Zhou Y, Bryant MF, Zhou T,
Luche DD, Nikolaishvili-Feinberg N, Simpson DA, Cordeiro-Stone M. Caffeine and human DNA
metabolism: The magic and the mystery. Mutat Res 2003;532:85–102. [PubMed: 14643431]
23. Juan G, Traganos F, James WM, Ray JM, Roberge M, Sauve DM, Anderson H, Darzynkiewicz Z.
Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during
their progression through G2 and mitosis. Cytometry 1998;32:71–7. [PubMed: 9627219]
24. Kaufmann WK, Levedakou EN, Grady HL, Paules RS, Stein GH. Attenuation of G2 checkpoint
function precedes human cell immortalization. Cancer Res 1995;55:7–11. [PubMed: 7805043]
25. Xu B, Kim ST, Lim DS, Kastan MB. Two molecularly distinct G2/M checkpoints are induced by
ionizing irradiation. Mol Cell Biol 2002;22:1049–59. [PubMed: 11809797]
26. Unsal-Kacmaz K, Mullen TE, Kaufmann WK, Sancar A. Coupling of human circadian and cell cycles
by the timeless protein. Mol Cell Biol 2005;25:3109–16. [PubMed: 15798197]
27. Cordeiro-Stone M, Boyer JC, Smith BA, Kaufmann WK. Effect of benzo[a]pyrene-diol-epoxide-I
on growth of nascent DNA in synchronized human fibroblasts. Carcinogenesis 1986;7:1775–81.
[PubMed: 3093114]
28. Chou JW, Paules RS, Bushel PR. Systematic variation normalization in microarray data to get gene
expression comparison unbiased. Journal of Bioinformatics and Computational Biology 2005;3:225–
41. [PubMed: 15852502]
29. Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y. Genome-wide in silico identification of
transcriptional regulators controlling the cell cycle in human cells. Genome Res 2003;13:773–80.
[PubMed: 12727897]
30. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, Hehl R, Hornischer K, Karas D, Kel AE,
Kel-Margoulis OV, Kloos DU, Land S, Lewicki-Potapov B, Michael H, Munch R, Reuter I, Rotert
S, Saxel H, Scheer M, Thiele S, Wingender E. TRANSFAC: Transcriptional regulation, from patterns
to profiles. Nucleic Acids Research 2003;31:374–8. [PubMed: 12520026]
31. Birney E, Andrews TD, Bevan P, Caccamo M, Chen Y, Clarke L, Coates G, Cuff J, Curwen V, Cutts
T, Down T, Eyras E, Fernandez-Suarez XM, Gane P, Gibbins B, Gilbert J, Hammond M, Hotz HR,
Iyer V, Jekosch K, Kahari A, Kasprzyk A, Keefe D, Keenan S, Lehvaslaiho H, McVicker G, Melsopp
C, Meidl P, Mongin E, Pettett R, Potter S, Proctor G, Rae M, Searle S, Slater G, Smedley D, Smith
J, Spooner W, Stabenau A, Stalker J, Storey R, Ureta-Vidal A, Woodwark KC, Cameron G, Durbin
R, Cox A, Hubbard T, Clamp M. An overview of Ensembl. Genome Res 2004;14:925–8. [PubMed:
15078858]
32. Russell L, Forsdyke DR. A human putative lymphocyte G0/G1 switch gene containing a CpG-rich
island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol
1991;10:581–91. [PubMed: 1930693]
Zhou et al. Page 10













33. Agarwal ML, Agarwal A, Taylor WR, Stark GR. p53 controls both the G2/M and the G1 cell cycle
checkpoints and mediates reversible growth arrest in human fibroblasts. Proc Natl Acad Sci USA
1995;92:8493–7. [PubMed: 7667317]
34. Iliakis G, Wang Y, Guan J, Wang H. DNA damage checkpoint control in cells exposed to ionizing
radiation. Oncogene 2003;22:5834–47. [PubMed: 12947390]
35. Burns TF, El-Deiry WS. Microarray analysis of p53 target gene expression patterns in the spleen and
thymus in response to ionizing radiation. Cancer Biol Ther 2003;2:431–43. [PubMed: 14508117]
36. Amundson SA, Bittner M, Meltzer P, Trent J, Fornace AJ Jr. Induction of gene expression as a monitor
of exposure to ionizing radiation. Radiat Res 2001;156:657–61. [PubMed: 11604088]
37. Sax JK, El-Deiry WS. p53 downstream targets and chemosensitivity. Cell Death Differ 2003;10:413–
7. [PubMed: 12719718]
38. Mirza A, Wu Q, Wang L, McClanahan T, Bishop WR, Gheyas F, Ding W, Hutchins B, Hockenberry
T, Kirschmeier P, Greene JR, Liu S. Global transcriptional program of p53 target genes during the
process of apoptosis and cell cycle progression. Oncogene 2003;22:3645–54. [PubMed: 12789273]
39. Taylor WR, DePrimo SE, Agarwal A, Agarwal ML, Schonthal AH, Katula KS, Stark GR.
Mechanisms of G2 arrest in response to overexpression of p53. Mol Biol Cell 1999;10:3607–22.
[PubMed: 10564259]
40. Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001;20:1803–15.
[PubMed: 11313928]
41. de Toledo SM, Azzam EI, Keng P, Laffrenier S, Little JB. Regulation by ionizing radiation of CDC2,
cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human
diploid fibroblasts is dependent on p53/p21Waf1. Cell Growth Differ 1998;9:887–96. [PubMed:
9831241]
42. Manni I, Mazzaro G, Gurtner A, Mantovani R, Haugwitz U, Krause K, Engeland K, Sacchi A, Soddu
S, Piaggio G. NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C
promoters upon induced G2 arrest. J Biol Chem 2001;276:5570–6. [PubMed: 11096075]
43. Innocente SA, Lee JM. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1
transcription. FEBS Lett 2005;579:1001–7. [PubMed: 15710382]
44. St Clair S, Giono L, Varmeh-Ziaie S, Resnick-Silverman L, Liu WJ, Padi A, Dastidar J, DaCosta A,
Mattia M, Manfredi JJ. DNA damage-induced downregulation of Cdc25C is mediated by p53 via
two independent mechanisms: One involves direct binding to the cdc25C promoter. Mol Cell
2004;16:725–36. [PubMed: 15574328]
45. Badie C, Itzhaki JE, Sullivan MJ, Carpenter AJ, Porter AC. Repression of CDK1 and other genes
with CDE and CHR promoter elements during DNA damage-induced G2/M arrest in human cells.
Mol Cell Biol 2000;20:2358–66. [PubMed: 10713160]
46. Lange-zu Dohna C, Brandeis M, Berr F, Mossner J, Engeland K. A CDE/CHR tandem element
regulates cell cycle-dependent repression of cyclin B2 transcription. FEBS Lett 2000;484:77–81.
[PubMed: 11068036]
Zhou et al. Page 11














Patterns of cell cycle-specific gene expression that were extracted using the EPIG method in
three immortalized normal human fibroblast cell lines, NHF1, NHF3 and NHF10. Gene
expression level is presented as log2 ratio of sample RNA against global reference RNA.
Patterns 1 and 2 include over 500 genes that were highly expressed in G1 phase but expressed
at relatively low levels in other cell phases; Patterns 3 through 7 include over 1100 genes whose
expression level was highest in S phase and lowest in G1 or M phases; Patterns 8 and 9 included
over 700 genes with maximal expression in M.
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Dynamic changes in cell cycle compartments at 2, 6 and 24 hr post-IR. Status of DNA synthesis
through the cell cycle was determined by BrdU incorporation. S represents S phase cell
population, G1 represents G1 phase cell population and G2 represents G2 phase cell population
(upper panels); Mitosis was determined by anti-phospho-histone H3 antibody. MI is mitotic
index that represents mitotic cell number (lower panels).
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Comparison of changes in expression level of selected target and non-target genes post IR-
irradiation. Actual changes in cell cycle-regulated genes post IR-irradiation were measured by
microarray (left), effects of cell synchronization on cell cycle-regulated genes were calculated
according to changes in cell cycle compartments (right). a shows target genes that were directly
trans-repressed by IR at early (6 hr) and late (24 hr) time points, b shows target genes that were
directly trans-repressed by IR at only late (24 hr) time point, c shows target genes that were
directly trans-induced by IR at late (24 hr) time point, d shows non-target genes whose actual
changes in expression levels were very close to those from effects of cell synchronization by
IR. The values depicted for each gene expression are the mean of three cell lines. Error bars
indicate SE.
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Table 3
Gene number and selected genes in each expression cycle-phase-specific pattern
Patterns No.* Selected Genes**
Pattern 1 236 (39) CASP1, CCRK, G0S2, SOX4, HMOX1, SUI1, TOP1MT
Pattern 2 287 (25) CREM, EEF2, EIF4A2, GFPT2, IL6, MYC, SOD2
Pattern 3 473 (95) ATR, CDC45L, CDC6, CDC7L1, CDKN2D, E2F1, EXO1, FANCA, FANCG, MCM2, MCM5,
MCM6, MSH2, POLA2, RFC2, RFC5, SNK (PLK2), TIMELESS, TUBA4, XRCC1, XRCC5,
Pattern 4 212 (15) ALDH1A3, CNK, DUSP6, EGR2, NCOR2, PIG8, CCNE1
Pattern 5 79 (16) CCNG2, H1F2, PIG3, RAD50
Pattern 6 19 (2) RFC4, RFC1
Pattern 7 358 (156) BARD1, BLM, BRCA1, BUB1, CCNB2, CDC2, CDCA1, CDK2, CDKN2C, CDKN3,
CHEK1, DDB2, MCM3, MCM7, ORC3L, ORC4L, ORC6L, PCNA, PLAB, POLB, POLE,
RAD1, RAD51, RAD54B, RAD54L, RFC3, SMC2L1, SOD1, TOP2A, TOPK, WEE1
Pattern 8 302 (45) ASK, BUB1B, CCNA2, CCNB1, CDC20, CDC25C, CDC27, CENPA, CENPE, PLK, POLG2,
RAD21
Pattern 9 444 (13) BAG3, BAG4, BNIP2, CDC2L5, CDK7, EIF5, HSPA1A, HSPA1L, HSPA8, ID3, TP53BP2
Total 2410 (406)
*
Numbers of cell cycle-regulated genes confirmed in normal cycling cell population are presented in the parentheses.
**
The list and expression levels through cell cycle phases of the 406 cell-cycle-regulated genes are provided as Supplementary (Table 8).
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Table 4
The proportions of cell cycle compartments in seven sham-treated NHF1 cells
G1 S G2 M
sham1 48.9 39.4 10.3 1.5
sham2 52.7 35.7 9.7 1.9
sham3 71.4 20.8 6.3 1.5
sham4 72.6 19.0 6.9 1.5
Sham5 73.1 19.6 5.9 1.4
Sham6 77.9 15.4 5.5 1.1
Sham7 83.0 10.5 6.0 0.5
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Table 7
Comparison of transcription factors (TFs) between target and non-target genes a
TF (TRAnSFAC Accnum) No. of genes Enrichment Factor* P-Value
Targets (150) NF-Y (M00287) 59 2.9 4.5 × 10−15
E2F (M00939) 35 4.4 5.7 × 10−12
CDE** 49 2.0 9.9 × 10−8
Non-targets (163) E2F (M00939) 36 2.9 8.7 × 10−7
USF (M00121) 30 2.0 3.3 × 10−5
NF-Y (M00775) 34 1.9 3.7 × 10−5
*
Enrichment factor: the ratio between the prevalence of the TF binding site hits in the target and the background sets.
**
PWM model for the CDE element were taken from [Cell cycle-dependent regulation of the human aurora B promoter BBRC 316:930-936 (2004).
Kimura M et al].
a
Putative hits of the enriched TFs as identified by PRIMA are provided as Supplementary (Table 10).
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